Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9394358
Gene signature for predicting prognosis of patients with solid tumors
granted patentUS 9394352
Immunogenic POTE peptides and methods of use
granted patentUS 9394316
Inhibitors of the plasmodial surface anion channel as antimalarials
granted patentUS 9388222
Modified Pseudomonas exotoxin A
granted patentUS 9382311
HIV-1 broadly neutralizing antibodies
granted patentUS 9370559
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number
granted patentUS 9364557
Fold-back diabody diphtheria toxin immunotoxin and methods of use
granted patentUS 9364448
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted patentUS 9359447
Anti-mesothelin chimeric antigen receptors
granted patentUS 9359418
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use
granted patentUS 9358285
Granulysin in immunotherapy
granted patentUS 9353353
Virus-like particles (VLPs) prepared from chikungunya virus structural proteins
granted patentUS 9352032
Live attenuated antigenically marked classical swine fever vaccine
granted patentUS 9346859
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
granted patentUS 9345748
Anti-SSX-2 T cell receptors and related materials and methods of use
granted patentUS 9341619
Hyposialylation disorders
granted patentUS 9334246
Substituted triazines for malaria treatment and chemoprophylaxis
granted patentUS 9333251
Vaccine for protection against Shigella sonnei disease
granted patentUS 9328391
Cloning and expression of HIV-1 DNA
granted patentUS 9328142
Lipopeptide inhibitors of RAS oncoproteins
granted patentUS 9326992
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting hum
granted patentUS 9326950
Self-assembling nanoparticles composed of transmembrane peptides and their application for
granted patentUS 9320786
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted patentUS 9321834
Anti-malarial compositions
granted